These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 11395379)

  • 1. Potential role of modifier genes influencing transforming growth factor-beta1 levels in the development of vascular defects in endoglin heterozygous mice with hereditary hemorrhagic telangiectasia.
    Bourdeau A; Faughnan ME; McDonald ML; Paterson AD; Wanless IR; Letarte M
    Am J Pathol; 2001 Jun; 158(6):2011-20. PubMed ID: 11395379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A murine model of hereditary hemorrhagic telangiectasia.
    Bourdeau A; Dumont DJ; Letarte M
    J Clin Invest; 1999 Nov; 104(10):1343-51. PubMed ID: 10562296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endoglin-deficient mice, a unique model to study hereditary hemorrhagic telangiectasia.
    Bourdeau A; Faughnan ME; Letarte M
    Trends Cardiovasc Med; 2000 Oct; 10(7):279-85. PubMed ID: 11343967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced endothelial secretion and plasma levels of transforming growth factor-beta1 in patients with hereditary hemorrhagic telangiectasia type 1.
    Letarte M; McDonald ML; Li C; Kathirkamathamby K; Vera S; Pece-Barbara N; Kumar S
    Cardiovasc Res; 2005 Oct; 68(1):155-64. PubMed ID: 15907823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood outgrowth endothelial cells from Hereditary Haemorrhagic Telangiectasia patients reveal abnormalities compatible with vascular lesions.
    Fernandez-L A; Sanz-Rodriguez F; Zarrabeitia R; Pérez-Molino A; Hebbel RP; Nguyen J; Bernabéu C; Botella LM
    Cardiovasc Res; 2005 Nov; 68(2):235-48. PubMed ID: 15993872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of ALK-1 and endoglin in newborns from families with hereditary hemorrhagic telangiectasia type 2.
    Abdalla SA; Pece-Barbara N; Vera S; Tapia E; Paez E; Bernabeu C; Letarte M
    Hum Mol Genet; 2000 May; 9(8):1227-37. PubMed ID: 10767348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mouse model for hereditary hemorrhagic telangiectasia has a generalized vascular abnormality.
    Torsney E; Charlton R; Diamond AG; Burn J; Soames JV; Arthur HM
    Circulation; 2003 Apr; 107(12):1653-7. PubMed ID: 12668501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patients with hereditary hemorrhagic telangiectasia have increased plasma levels of vascular endothelial growth factor and transforming growth factor-beta1 as well as high ALK1 tissue expression.
    Sadick H; Riedel F; Naim R; Goessler U; Hörmann K; Hafner M; Lux A
    Haematologica; 2005 Jun; 90(6):818-28. PubMed ID: 15951295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic and molecular pathogenesis of hereditary hemorrhagic telangiectasia.
    Azuma H
    J Med Invest; 2000 Aug; 47(3-4):81-90. PubMed ID: 11019486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hereditary hemorrhagic telangiectasia, a vascular dysplasia affecting the TGF-beta signaling pathway.
    Fernández-L A; Sanz-Rodriguez F; Blanco FJ; Bernabéu C; Botella LM
    Clin Med Res; 2006 Mar; 4(1):66-78. PubMed ID: 16595794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A hereditary haemorrhagic telangiectasia family with pulmonary involvement is unlinked to the known HHT genes, endoglin and ALK-1.
    Wallace GM; Shovlin CL
    Thorax; 2000 Aug; 55(8):685-90. PubMed ID: 10899246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular endothelial growth factor induces abnormal microvasculature in the endoglin heterozygous mouse brain.
    Xu B; Wu YQ; Huey M; Arthur HM; Marchuk DA; Hashimoto T; Young WL; Yang GY
    J Cereb Blood Flow Metab; 2004 Feb; 24(2):237-44. PubMed ID: 14747750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutation analysis in Spanish patients with hereditary hemorrhagic telangiectasia: deficient endoglin up-regulation in activated monocytes.
    Sanz-Rodriguez F; Fernandez-L A; Zarrabeitia R; Perez-Molino A; Ramírez JR; Coto E; Bernabeu C; Botella LM
    Clin Chem; 2004 Nov; 50(11):2003-11. PubMed ID: 15375013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic abnormalities in hereditary hemorrhagic telangiectasia.
    Marchuk DA
    Curr Opin Hematol; 1998 Sep; 5(5):332-8. PubMed ID: 9776212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hereditary haemorrhagic telangiectasia: current views on genetics and mechanisms of disease.
    Abdalla SA; Letarte M
    J Med Genet; 2006 Feb; 43(2):97-110. PubMed ID: 15879500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced plasma levels of Ang-2 and sEng as novel biomarkers in hereditary hemorrhagic telangiectasia (HHT).
    Ojeda-Fernandez L; Barrios L; Rodriguez-Barbero A; Recio-Poveda L; Bernabeu C; Botella LM
    Clin Chim Acta; 2010 Apr; 411(7-8):494-9. PubMed ID: 20067780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel missense mutation in the endoglin gene in hereditary hemorrhagic telangiectasia.
    Yamaguchi H; Azuma H; Shigekiyo T; Inoue H; Saito S
    Thromb Haemost; 1997 Feb; 77(2):243-7. PubMed ID: 9157574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hereditary haemorrhagic telangiectasia: a questionnaire based study to delineate the different phenotypes caused by endoglin and ALK1 mutations.
    Berg J; Porteous M; Reinhardt D; Gallione C; Holloway S; Umasunthar T; Lux A; McKinnon W; Marchuk D; Guttmacher A
    J Med Genet; 2003 Aug; 40(8):585-90. PubMed ID: 12920067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutation and expression analysis of the endoglin gene in hereditary hemorrhagic telangiectasia reveals null alleles.
    Gallione CJ; Klaus DJ; Yeh EY; Stenzel TT; Xue Y; Anthony KB; McAllister KA; Baldwin MA; Berg JN; Lux A; Smith JD; Vary CP; Craigen WJ; Westermann CJ; Warner ML; Miller YE; Jackson CE; Guttmacher AE; Marchuk DA
    Hum Mutat; 1998; 11(4):286-94. PubMed ID: 9554745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endoglin, an ancillary TGFbeta receptor, is required for extraembryonic angiogenesis and plays a key role in heart development.
    Arthur HM; Ure J; Smith AJ; Renforth G; Wilson DI; Torsney E; Charlton R; Parums DV; Jowett T; Marchuk DA; Burn J; Diamond AG
    Dev Biol; 2000 Jan; 217(1):42-53. PubMed ID: 10625534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.